• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中东呼吸综合征冠状病毒的抗病毒活性的阴离子和阳离子聚酰胺-胺树枝状大分子的初步研究。

A pilot study of the antiviral activity of anionic and cationic polyamidoamine dendrimers against the Middle East respiratory syndrome coronavirus.

机构信息

Department of Biomedical Sciences, College of Veterinary Medicine, King Faisal University, Al-Ahsa, Saudi Arabia.

Department of Pharmacology, Faculty of Veterinary Medicine, Kafrelsheikh University, Kafrelsheikh, Egypt.

出版信息

J Med Virol. 2020 Sep;92(9):1665-1670. doi: 10.1002/jmv.25928. Epub 2020 May 8.

DOI:10.1002/jmv.25928
PMID:32330296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7264540/
Abstract

The Middle East respiratory syndrome coronavirus (MERS-CoV) is an emerging virus that causes infection with a potentially fatal outcome. Dendrimers are highly branched molecules that can be added to antiviral preparations to improve their delivery, as well as their intrinsic antiviral activity. Studies on identifying anti-MERS-CoV agents are few. Three types of polyanionic dendrimers comprising the terminal groups sodium carboxylate (generations 1.5, 2.5, 3.5, and 4.5), hydroxyl (generations 2, 3, 4, and 5), and succinamic acid (generations 2, 3, 4, and 5) and polycationic dendrimers containing primary amine (generations 2, 3, 4, and 5) were used to assess their antiviral activity with the MERS-CoV plaque inhibition assay. The hydroxyl polyanionic set showed a 17.36% to 29.75% decrease in MERS-CoV plaque formation. The most potent inhibition of MERS-CoV plaque formation was seen by G(1.5)-16COONa (40.5% inhibition), followed by G(5)-128SA (39.77% inhibition). In contrast, the cationic dendrimers were cytotoxic to Vero cells. Polyanionic dendrimers can be added to antiviral preparations to improve the delivery of antivirals, as well as the intrinsic antiviral activity.

摘要

中东呼吸综合征冠状病毒(MERS-CoV)是一种新兴病毒,可导致感染,具有潜在致命后果。树枝状大分子是高度分支的分子,可以添加到抗病毒制剂中,以改善其递送以及内在的抗病毒活性。鉴定抗 MERS-CoV 药物的研究很少。使用了三种类型的带负电荷的树枝状大分子,其末端基团为羧酸钠(1.5 代、2.5 代、3.5 代和 4.5 代)、羟基(2 代、3 代、4 代和 5 代)和琥珀酸(2 代、3 代、4 代和 5 代)以及带正电荷的树枝状大分子,其中包含伯胺(2 代、3 代、4 代和 5 代),以评估它们在 MERS-CoV 蚀斑抑制测定中的抗病毒活性。羟基带负电荷的树枝状大分子使 MERS-CoV 蚀斑形成减少了 17.36%至 29.75%。对 MERS-CoV 蚀斑形成的抑制作用最强的是 G(1.5)-16COONa(抑制率为 40.5%),其次是 G(5)-128SA(抑制率为 39.77%)。相比之下,阳离子树枝状大分子对 Vero 细胞具有细胞毒性。带负电荷的树枝状大分子可以添加到抗病毒制剂中,以改善抗病毒药物的递送,以及内在的抗病毒活性。

相似文献

1
A pilot study of the antiviral activity of anionic and cationic polyamidoamine dendrimers against the Middle East respiratory syndrome coronavirus.中东呼吸综合征冠状病毒的抗病毒活性的阴离子和阳离子聚酰胺-胺树枝状大分子的初步研究。
J Med Virol. 2020 Sep;92(9):1665-1670. doi: 10.1002/jmv.25928. Epub 2020 May 8.
2
3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.3C 样蛋白酶抑制剂可阻断冠状病毒在体外的复制,并改善 MERS-CoV 感染小鼠的存活率。
Sci Transl Med. 2020 Aug 19;12(557). doi: 10.1126/scitranslmed.abc5332. Epub 2020 Aug 3.
3
Effective inhibition of MERS-CoV infection by resveratrol.白藜芦醇对中东呼吸综合征冠状病毒感染的有效抑制作用。
BMC Infect Dis. 2017 Feb 13;17(1):144. doi: 10.1186/s12879-017-2253-8.
4
Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.对一个经美国食品药品监督管理局批准的化合物文库进行筛选,鉴定出四种在细胞培养中可抑制中东呼吸综合征冠状病毒复制的小分子抑制剂。
Antimicrob Agents Chemother. 2014 Aug;58(8):4875-84. doi: 10.1128/AAC.03011-14. Epub 2014 May 19.
5
Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin.中东呼吸综合征冠状病毒感染受到格里菲斯菌素的抑制。
Antiviral Res. 2016 Sep;133:1-8. doi: 10.1016/j.antiviral.2016.07.011. Epub 2016 Jul 15.
6
Antiviral activity against Middle East Respiratory Syndrome coronavirus by Montelukast, an anti-asthma drug.孟鲁司特钠(一种治疗哮喘的药物)抗中东呼吸综合征冠状病毒的抗病毒活性。
Antiviral Res. 2021 Jan;185:104996. doi: 10.1016/j.antiviral.2020.104996. Epub 2020 Dec 10.
7
Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity.一系列具有抗冠状病毒活性的非环状柔性核苷类似物的设计、合成与评价
Bioorg Med Chem Lett. 2015 Aug 1;25(15):2923-6. doi: 10.1016/j.bmcl.2015.05.039. Epub 2015 May 23.
8
In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.紫锥菊制剂 Echinaforce®抗冠状病毒(包括普通感冒冠状病毒 229E 和 SARS-CoV-2)的体外病毒杀灭活性。
Virol J. 2020 Sep 9;17(1):136. doi: 10.1186/s12985-020-01401-2.
9
Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus.广谱抗病毒药物治疗新兴的中东呼吸综合征冠状病毒感染。
J Infect. 2013 Dec;67(6):606-16. doi: 10.1016/j.jinf.2013.09.029. Epub 2013 Oct 3.
10
Inhibition of Stress Granule Formation by Middle East Respiratory Syndrome Coronavirus 4a Accessory Protein Facilitates Viral Translation, Leading to Efficient Virus Replication.中东呼吸综合征冠状病毒 4a 辅助蛋白抑制应激颗粒形成,促进病毒翻译,导致病毒高效复制。
J Virol. 2018 Sep 26;92(20). doi: 10.1128/JVI.00902-18. Print 2018 Oct 15.

引用本文的文献

1
Effect of multifunctional cationic polymer coatings on mitigation of broad microbial pathogens.多功能阳离子聚合物涂层对减轻广谱微生物病原体的影响。
Microbiol Spectr. 2024 Sep 3;12(9):e0409723. doi: 10.1128/spectrum.04097-23. Epub 2024 Aug 5.
2
Nanoparticles as delivery vehicles for antiviral therapeutic drugs.纳米颗粒作为抗病毒治疗药物的递送载体。
Eng Regen. 2021;2:31-46. doi: 10.1016/j.engreg.2021.03.001. Epub 2021 Mar 24.
3
Nanomedicine for the Treatment of Viral Diseases: Smaller Solution to Bigger Problems.用于治疗病毒性疾病的纳米医学:解决大问题的更小方案。
Pharmaceutics. 2024 Mar 16;16(3):407. doi: 10.3390/pharmaceutics16030407.
4
A Molecular Dynamics Simulation of Complexes of Fullerenes and Lysine-Based Peptide Dendrimers with and without Glycine Spacers.富勒烯与赖氨酸基肽树枝状大分子复合物的分子动力学模拟:有无甘氨酸间隔物。
Int J Mol Sci. 2024 Jan 5;25(2):691. doi: 10.3390/ijms25020691.
5
Recent Updates on Multifunctional Nanomaterials as Antipathogens in Humans and Livestock: Classification, Application, Mode of Action, and Challenges.多功能纳米材料作为人类和家畜抗病原体的最新研究进展:分类、应用、作用模式和挑战。
Molecules. 2023 Nov 20;28(22):7674. doi: 10.3390/molecules28227674.
6
Superior possibilities and upcoming horizons for nanoscience in COVID-19: noteworthy approach for effective diagnostics and management of SARS-CoV-2 outbreak.纳米科学在2019冠状病毒病中的卓越潜力与未来前景:针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)爆发进行有效诊断与管理的重要方法
Chem Zvesti. 2023 Apr 4:1-24. doi: 10.1007/s11696-023-02795-3.
7
Advances in Antiviral Delivery Systems and Chitosan-Based Polymeric and Nanoparticulate Antivirals and Antiviral Carriers.抗病毒传递系统的进展及壳聚糖基聚合物和纳米颗粒抗病毒药物和抗病毒载体。
Viruses. 2023 Feb 28;15(3):647. doi: 10.3390/v15030647.
8
An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19.基于纳米颗粒的策略对抗病毒感染的概述,重点关注 COVID-19。
J Nanobiotechnology. 2022 Oct 8;20(1):440. doi: 10.1186/s12951-022-01625-0.
9
Significant perspectives on various viral infections targeted antiviral drugs and vaccines including COVID-19 pandemicity.关于包括COVID-19大流行在内的各种病毒感染、靶向抗病毒药物和疫苗的重要观点。
Mol Biomed. 2022 Jul 15;3(1):21. doi: 10.1186/s43556-022-00078-z.
10
Nanostructures for drug delivery in respiratory diseases therapeutics: Revision of current trends and its comparative analysis.用于呼吸系统疾病治疗中药物递送的纳米结构:当前趋势综述及其比较分析
J Drug Deliv Sci Technol. 2022 Apr;70:103219. doi: 10.1016/j.jddst.2022.103219. Epub 2022 Mar 5.

本文引用的文献

1
Small Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Fusion by Targeting Cavities on Heptad Repeat Trimers.通过靶向七聚体重复三聚体上的腔来抑制中东呼吸综合征冠状病毒融合的小分子抑制剂
Biomol Ther (Seoul). 2020 Jul 1;28(4):311-319. doi: 10.4062/biomolther.2019.202.
2
Risk Factors for Fatal Middle East Respiratory Syndrome Coronavirus Infections in Saudi Arabia: Analysis of the WHO Line List, 2013-2018.沙特阿拉伯 2013-2018 年世卫组织名单中致命中东呼吸综合征冠状病毒感染的危险因素分析。
Am J Public Health. 2019 Sep;109(9):1288-1293. doi: 10.2105/AJPH.2019.305186. Epub 2019 Jul 18.
3
G2-S16 sulfonate dendrimer as new therapy for treatment failure in HIV-1 entry inhibitors.G2-S16 磺酸酯树枝状大分子作为治疗 HIV-1 进入抑制剂治疗失败的新方法。
Nanomedicine (Lond). 2019 May;14(9):1095-1107. doi: 10.2217/nnm-2018-0364. Epub 2019 May 8.
4
Development of Small-Molecule MERS-CoV Inhibitors.小分子 MERS-CoV 抑制剂的研发。
Viruses. 2018 Dec 17;10(12):721. doi: 10.3390/v10120721.
5
Inherent anti-HIV activity of biocompatible anionic citrate-PEG-citrate dendrimer.生物相容性阴离子柠檬酸-聚乙二醇-柠檬酸树枝状大分子的固有抗HIV活性。
Mol Biol Rep. 2019 Feb;46(1):143-149. doi: 10.1007/s11033-018-4455-6. Epub 2018 Nov 9.
6
Generation and characterization of a monoclonal antibody against MERS-CoV targeting the spike protein using a synthetic peptide epitope-CpG-DNA-liposome complex.利用合成肽表位-CpG-DNA-脂质体复合物生成并鉴定针对 MERS-CoV 刺突蛋白的单克隆抗体。
BMB Rep. 2019 Jun;52(6):397-402. doi: 10.5483/BMBRep.2019.52.6.185.
7
Effective inhibition of MERS-CoV infection by resveratrol.白藜芦醇对中东呼吸综合征冠状病毒感染的有效抑制作用。
BMC Infect Dis. 2017 Feb 13;17(1):144. doi: 10.1186/s12879-017-2253-8.
8
MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study.韩国一家急诊室因一名患者暴露引发中东呼吸综合征冠状病毒(MERS-CoV)疫情:一项流行病学疫情研究
Lancet. 2016 Sep 3;388(10048):994-1001. doi: 10.1016/S0140-6736(16)30623-7. Epub 2016 Jul 9.
9
Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease.中东呼吸综合征冠状病毒:另一种引起类似严重急性呼吸综合征疾病的人畜共患β冠状病毒。
Clin Microbiol Rev. 2015 Apr;28(2):465-522. doi: 10.1128/CMR.00102-14.
10
Comparative toxicological assessment of PAMAM and thiophosphoryl dendrimers using embryonic zebrafish.使用斑马鱼胚胎对聚酰胺-胺型(PAMAM)和硫代磷酰树枝状大分子进行比较毒理学评估。
Int J Nanomedicine. 2014 Apr 17;9:1947-56. doi: 10.2147/IJN.S60220. eCollection 2014.